Sabra Health Care REIT’s (SBRA) Buy Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald restated their buy rating on shares of Sabra Health Care REIT Inc (NASDAQ:SBRA) in a report issued on Friday, September 8th. The firm currently has a $30.00 target price on the real estate investment trust’s stock. Cantor Fitzgerald also issued estimates for Sabra Health Care REIT’s FY2017 earnings at $2.27 EPS and FY2018 earnings at $2.31 EPS.

“We expect investors to be pleased that SBRA’s restructuring of selected underperforming leases acquired in last months combination with CCP appears to eliminate the poor coverage issues at Signature and other operators, and demonstrate substantially more accretion from CCP than we had assumed.”,” Cantor Fitzgerald’s analyst commented.

Several other research firms also recently weighed in on SBRA. BidaskClub raised shares of Sabra Health Care REIT from a sell rating to a hold rating in a research report on Tuesday, June 20th. Mizuho reaffirmed a neutral rating on shares of Sabra Health Care REIT in a report on Wednesday, June 28th. Zacks Investment Research lowered shares of Sabra Health Care REIT from a hold rating to a sell rating in a research note on Thursday, June 8th. Stifel Nicolaus reissued a hold rating and set a $26.00 target price on shares of Sabra Health Care REIT in a research note on Friday, July 28th. Finally, Jefferies Group LLC reissued a hold rating and set a $28.00 target price on shares of Sabra Health Care REIT in a research note on Friday, May 12th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average target price of $25.00.

Shares of Sabra Health Care REIT (NASDAQ:SBRA) traded up 0.47% during midday trading on Friday, hitting $23.46. The stock had a trading volume of 2,926,284 shares. The firm’s 50 day moving average price is $22.35 and its 200 day moving average price is $24.66. Sabra Health Care REIT has a 52-week low of $19.30 and a 52-week high of $29.10. The firm has a market cap of $1.54 billion, a price-to-earnings ratio of 19.75 and a beta of 0.89.

ILLEGAL ACTIVITY WARNING: “Sabra Health Care REIT’s (SBRA) Buy Rating Reaffirmed at Cantor Fitzgerald” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/09/16/sabra-healthcare-reit-inc-sbra-receives-buy-rating-from-cantor-fitzgerald.html.

The company also recently declared a quarterly dividend, which was paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th were issued a dividend of $0.3599 per share. The ex-dividend date was Monday, August 14th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 6.14%. Sabra Health Care REIT’s dividend payout ratio is currently 122.03%.

Several hedge funds have recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Sabra Health Care REIT by 14.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock valued at $106,000 after purchasing an additional 471 shares in the last quarter. Bank of Montreal Can grew its position in Sabra Health Care REIT by 44.1% during the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock valued at $109,000 after purchasing an additional 1,191 shares in the last quarter. Ameritas Investment Partners Inc. purchased a new position in Sabra Health Care REIT during the first quarter valued at approximately $156,000. Daiwa Securities Group Inc. grew its position in Sabra Health Care REIT by 15.7% during the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock valued at $142,000 after purchasing an additional 800 shares in the last quarter. Finally, Riverhead Capital Management LLC grew its position in Sabra Health Care REIT by 96.0% during the second quarter. Riverhead Capital Management LLC now owns 6,861 shares of the real estate investment trust’s stock valued at $165,000 after purchasing an additional 3,361 shares in the last quarter. Institutional investors and hedge funds own 99.26% of the company’s stock.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply